Donate | 100% goes directly to research

Evaluation of Sleep-EEG in Transgenic Mice

2017

PsychoGenics will carry out EEG readings of sleeping and awake ACE1 transgenic mice containing genetic variants identified by Genome-Wide Association Studies (GWAS) for their impact on Alzheimer’s disease risk. This research is being conducted in conjunction with Robert Vassar, Ph.D.’s project “Molecular and Cellular Mechanisms of ACE1 Variant in Alzheimer’s Disease.”

PsychoGenics Studies of Alternative Neurodegenerative Pathways Translational

In Vivo Models for Golgi Fragmentation and the Molecular Pathogenesis of Alzheimer’s Disease

Marc Weinberg, Steven Arnold,

Functional Changes to Cerebrospinal Fluid Immune Cells Resulting from Bacillus Calmette-Guérin (BCG) Vaccination in Older Adults With and Without Alzheimer’s Disease

Deepak Kumar Vijaya Kumar, | 2023

Characterizing Gut Bacteriome-Mycobiome Synergy in Correlation to Amylin-Amyloid Beta Antimicrobial Synergy in Alzheimer’s Disease (AD) in AD Mouse Models

Eran Elinav, | 2023

Decoding Microbial Products Modulating Alzheimer’s Disease—Toward Precision Postbiotics Treatment

Se Hoon Choi, | 2023

Brain Entry and Exit Consortium: A 3D In Vitro Neurovascular Human Brain Model With Meningeal Lymphatics for Elucidating Mechanisms Underlying Alzheimer’s Disease

William Van Nostrand, | 2023

Effect of APOE Genotype in a Novel Rat Model of Cerebral Amyloid Angiopathy

Saul Villeda, | 2022

Role of the Circulating Exerkine GPLD1 in Ameliorating Alzheimer’s Disease Pathology

Srdjan D. Antic, Riqiang Yan, | 2022

Alzheimer’s Disease Pathophysiology Alters the Level of Electrical and Chemical Synapse Coupling in the Network of GABAergic PV+ Interneurons Early in Disease Course

Evaluation of Sleep-EEG in Transgenic Mice

Funding to Date

Focus

Researchers

Related Content: